Effects of long-term captopril and L-arginine treatment on ventilation and blood pressure in obese male SHHF rats

Journal of Applied Physiology

Volumn 97, Issue 3, 2004, Pages 1032-1039

  Schlenker, E H ^a   Kost Jr , C K ^a   Likness, M M ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Frequency; Hypertension; Metabolic syndrome X; Spontaneously hypertensive heart failure rat; Ventilatory equivalent

Indexed keywords

ARGININE; CAPTOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BREATHING; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HYPERTENSION; HYPOVENTILATION; LIPID METABOLISM; LONG TERM CARE; LUNG VENTILATION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RISK FACTOR; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARGININE; BLOOD PRESSURE; CAPTOPRIL; HYPERTENSION, PULMONARY; HYPOVENTILATION; MALE; OBESITY; OXYGEN CONSUMPTION; PULMONARY VENTILATION; RATS; TREATMENT OUTCOME;

EID: 4344717030     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00255.2004     Document Type: Article

References (53)

1. Braunwald E and Grossman W. Clinical aspects of heart failure. In: Heart Disease. Philadelphia, PA: Saunders, 1992, p. 444-463.
2. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, and Labarthe D. Prevalence of hypertension in the US adult population. Results from the third national health and nutrition examination survey, 1988-1991. Hypertension 25: 303-313, 1995.
3. Calapai G, Corica F, Allegra A, Corsonello A, Sautebin L, Gregorio TD, Rosa MD, Costantino G, Buemi M, and Caputi AP. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. Br J Pharmacol 125: 798-802, 1998.
4. Carley DW, Berecek K, Videnovic A, and Radulovacki M. Sleep-disordered respiration in phenotypically normotensive, genetically hypertensive rats. Am J Respir Crit Care Med 162: 1474-1479, 2000.
5. Carraway JW, Park S, McCune SA, Holycross BJ, and Radin MJ. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats. J Cardiovasc Pharmacol 33: 451-460, 1999.
6. Chen S, Su J, Wu K, Hu W, Gardner DG, and Chen D. Early captopril treatment prevents hypertrophy-dependent gene expression in hearts of SHR. Am J Physiol Regul Integr Comp Physiol 274: R1511-R1517, 1998.
7. Clark AL, Poole-Wilson PA, and Coats AJS. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28: 1092-1102, 1996.
8. Coughlin S, Calverley P, and Wilding J. Sleep disorder breathing - a new component of syndrome X? Obes Rev 2: 267-274, 2001.
9. Cowley AW, Mattson DL, Lu S, and Roman RJ. The renal medulla and hypertension. Hypertension 25: 663-673, 1995.
10. Crisp AJ, Tutt SM, McGregor KH, and Hainsworth R. The effects of changes in left ventricular pressure on respiratory activity in anesthetized dogs. Q J Exp Physiol 74: 291-300, 1989.
11. Farkas GA and Schlenker EH. Pulmonary ventilation and mechanics in morbidly obese Zucker rats. Am J Respir Crit Care Med 150: 356-362, 1994.
12. Forster J, Beebe P, Wang H, and Wood JG. The effect of nitric oxide inhibition on blood pressure depends on rat strain. J Surg Res 96: 218-223, 2001.
13. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas H, Liang C, Kubo SH, Rudin-Toretsky E, and Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 82: 1724-1729, 1990.
14. Freslon JL and Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 80: 533-543, 1983.
15. cp Rats. J Appl Physiol 77: 534-541, 1994.
16. Gardiner SM, Compton AM, Bennett T, Palmer RMJ, and Moncada S. Control of regional blood flow by the endothelium-derived nitric oxide. Hypertension 15: 486-492, 1990.
17. Granstam SO, Granstam E, Fellström B, and Lind L. Regional haemodynamic differences between normotensive and spontaneously hypertensive rats - a microsphere study. Physiol Res 47: 9-15, 1998.
18. 2 output during exercise in chronic heart failure. Circulation 84: 605-612, 1991.
19. Hamilton RJ, Carter WA, and Gallagher EJ. Rapid improvement of acute pulmonary edema with sublingual captopril. Acad Emerg Med 3: 205-212, 1996.
20. Harper SL. Effects of antihypertensive treatment on cerebral microvasculature of spontaneously hypertensive rats. Stroke 18: 450-456, 1987.
21. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, and Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 16: 603-614, 1990.
22. Haxhiu MA, Chang CH, Dreshaj IA, Erokwu B, Prabhakar NR, and Cherniack NS. Nitric oxide and ventilatory response to hypoxia. Respir Physiol 101: 257-266, 1995.
23. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355: 253-259, 2000.
24. Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, and Cao Z. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Clin Sci (Lond) 104: 341-347, 2003.
25. Lommi J, Pulkki K, Koskinen P, Naveri H, Leinonen H, Harkonen M, and Kupari M. Hemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J 18: 1620-1625, 1997.
26. Ma S, Abboud FM, and Felder RB. Effects of L-arginine-derived nitric oxide synthesis on neuronal activity in nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 268: R487-R491, 1995.
27. 2 ratio in myocardial infarction patients with low ejection fraction. Chest 114: 1289-1294, 1998.
28. McCune SA, Baker PB, and Stills HF Jr. SHHF/Mcc-cp Rat: model of obestiy, non-insulin-dependent diabetes, and congestive heart failure. ILAR News 32: 23-27, 1990.
29. Morley JE and Mattammal MB. Nitric oxide synthase levels in obese Zucker rats. Neurosci Lett 209: 137-139, 1996.
30. Nakano H, Lee SD, Ray AD, Krasney JA, and Farkas GA. Role of nitric oxide in thermoregulation and hypoxic ventilatory response in obese Zucker rats. Am J Respir Crit Care Med 164: 437-442, 2001.
31. O'Donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, and Smith PL. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 159: 1477-1484, 1999.
32. Ogawa H, Mizusawa A, Kikuchi Y, Hida W, Miki H, and Shirato K. Nitric oxide as a retrograde messenger in the nucleus tractus solitarii of rats during hypoxia. J Physiol 486: 495-504, 1995.
33. Ono H, Ono Y, and Frohlich ED. L-Arginine reverses severe nephrosclerosis in aged spontaneously hypertensive rats. J Hypertens 17: 121-128, 1999.
34. Pollock DM and Rekito A. Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers. Am J Physiol Regul Integr Comp Physiol 275: R1719-R1723, 1998.
35. Polotsky VY, Wilson JA, Haines AS, Scharf MT, Soutiere SE, Tankersley CG, Smith PL, Schwartz AR, and O'Donnell CP. The impact of insulin-dependent diabetes on ventilatory control in the mouse. Am J Respir Crit Care Med 163: 624-632, 2001.
36. Quesada A, Sainz J, Wangensteen R, Rodriguez-Gomez I, Vargas F, and Osuna A. Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol 147: 117-122, 2002.
37. Radin MJ, Holycross BJ, Hoepf TM, and McCune SA. Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem 242: 57-63, 2003.
38. Radin MJ, Holycross BJ, Sharkey LC, Shiry L, and McCune SA. Gender modulates activation of renin-angiotensin and endothelin systems in hypertension and heart failure. J Appl Physiol 92: 935-940, 2002.
39. Romero JC, Lahera V, Salom MG, and Biondi ML. Role of the endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol 2: 1371-1387, 1992.
40. Schlenker EH, Tamura T, and Gerdes AM. Gender-specific effects of thyroid hormones on cardiopulmonary function in SHHF rats. J Appl Physiol 95: 2292-2298, 2003.
41. Schrier RW. Treating high-risk diabetic hypertensive patients with co-morbid conditions. Am J Kidney Dis 36: S10-S17, 2000.
42. Strohl KP and Thomas AJ. Ventilatory behavior and metabolism in two strains of obese rats. Respir Physiol 124: 85-93, 2001.
43. Subraamanian S, Erokwu B, Han F, Dick TE, and Strohl KP. L-NAME differentially alters ventilatory behavior in Sprague-Dawley and Brown Norway rats. J Appl Physiol 93: 984-989, 2002.
44. Susie D, Fracischetti A, and Frohlich ED. Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats. Hypertension 33: 451-455, 1999.
45. Tamirisa P, Frishman WH, and Kumar A. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am Heart J 130: 601-610, 1995.
46. Tankersley C, Kleeberger S, Russ B, Schwartz A, and Smith P. Modified control of breathing in genetically obese (ob/ob) mice. J Appl Physiol 81: 716-723, 1996.
47. Tasali E and Van Cauter E. Sleep-disorder breathing and the current epidemic of obesity. Am J Respir Crit Care Med 165: 562-563, 2002.
48. Tofovic SP, Kost CK Jr, Jackson EK, and Bastacky SI. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 [fa-fa(cp)] rats. Kidney Int 61: 1433-1444, 2002.
49. Wannamethee SG, Shaper AG, Durrington PN, and Perry IJ. Hypertension, serum insulin, obesity, and metabolic syndrome. J Hum Hypertens 12: 735-741, 1998.
50. White CR, Parks DA, Patel RP, Shelton J, Tarpey MM, Freeman BA, and Darley-Usmar VM. L-Arginine inhibits xanthine oxidase-dependent endothelial dysfunction in hypercholesterolemia. FEBS Lett 561: 94-98, 2004.
51. World Health Organization. 1999 World Health Organization international Society of Hypertension guidelines for the management of hypertension: guidelines subcommittee. J Hypertens 17: 151-183, 1999.
52. Wu JN and Berecek KH. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 22: 139-146, 1993.
53. Xu ZH, Shimakura K, Yamamoto T, Wang LM, and Mineshita S. Pulmonary edema induced by angiotensin I in rats. Jpn J Pharmacol 76: 51-56, 1998.